TYP 3.13% 3.3¢ tryptamine therapeutics limited

Ann: Maiden dosing of TRP-8803 completed in global first, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 146 Posts.
    lightbulb Created with Sketch. 39
    If one investigates the profound positives that psilocybin offers many neurological illnesses, TRP-8803 will be a game changer once this drug becomes standard care, this is because it's the only way the drug can be confidently and safely administered to patients.
 
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
3.3¢
Change
0.001(3.13%)
Mkt cap ! $35.93M
Open High Low Value Volume
3.2¢ 3.4¢ 3.2¢ $186.3K 5.674M

Buyers (Bids)

No. Vol. Price($)
1 8742 3.3¢
 

Sellers (Offers)

Price($) Vol. No.
3.4¢ 217109 3
View Market Depth
Last trade - 16.10pm 01/11/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.